Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Mangoceuticals Inc. Common Stock
MGRX | US
0.16
USD-0.19
-54.51%
MGRX | US
About Mangoceuticals Inc. Common Stock
Sector
Healthcare
Industry
Health Information Services
Earnings date
30/06/2024
As of date
20/03/2026
Close
0.16
Open
0.35
High
0.35
Low
0.16
Mangoceuticals Inc. focuses on develops markets and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals Inc. was incorporated in 2021 and is headquartered in Dallas Texas. Mangoceuticals Inc. operates as a subsidiary of Cohen Enterprises Inc.
View LessMGRX | US
Risk
262.9
Sharpe
-0.66
Luna's Score
46/100
Recommendation
Hold
Luna says (MGRX | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
270.7%1 month
262.9%3 months
207.6%6 months
178.2%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.44
Debt to equity
0.02
Debt to assets
0.02
Ent. to EBITDA
-0.51
Ent. to rev.
6.80
PEG
-
Other Fundamentals
EBITDA
-8.51M
MarketCap
388.80K
MarketCap(USD)
388.80K
Div. yield
-
Op. margin
-1.30K
Erngs. growth
-
Rev. growth
15.50
Ret. on equity
-108.44
Short ratio
0.44
Short perc.
0.48
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.24
Range1M
0.53
Range3M
0.91
Volumes: Market Activity
Rel. volume
0.19
Price X volume
585.14K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.51 | - | Cheaper |
| Ent. to Revenue | 6.80 | - | Cheaper |
| PE Ratio | - | 64.03 | - |
| Price to Book | 0.44 | 6.17 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 207.58 | - | Riskier |
| Debt to Equity | 0.02 | 0.44 | Cheaper |
| Debt to Assets | 0.02 | 0.35 | Cheaper |
| Market Cap | 388.80K | - | Emerging |
